Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure

Objectives: To the best of our knowledge, data from Gemtuzumab ozogamicin in Acute Myeloid Leukemia (AML) patients with failure of organ functions and poor performance status are extremely lacking. Moreover, the fast recovery from organ failure, after Gemtuzumab ozogamicin administration, has never...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaytsev, Daniil, Girshova, Larisa, Ivanov, Vladimir, Budaeva, Irina, Motorin, Dmitri, Badaev, Renat, Mirolubova, Julia, Grobovenko, Evgeni, Chitanava, Tamara, Zaykova, Ekaterina, Alexeeva, Julia, Zaritskey, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167863/
https://www.ncbi.nlm.nih.gov/pubmed/32050707
http://dx.doi.org/10.3390/biology9020028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167863/
https://www.ncbi.nlm.nih.gov/pubmed/32050707
http://dx.doi.org/10.3390/biology9020028

Ejemplares similares